Development of Patient-Specific Neurons in Schizophrenia Using Induced Pluripotent Stem Cells
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Induced pluripotent stem cell (iPSC) technology has the potential to transform regenerative medicine. It also offers a powerful tool for establishing in vitro models of disease, in particular, for neuropsychiatric disorders where live human neurons are essentially impossible to procure. Using iPSCs derived from three schizophrenia (SZ) patients, one of whom has 22q11.2del (velocardiofacial syndrome; VCFS), the authors developed a culture system to study SZ on a molecular and cellular level. SZ iPSCs were differentiated into functional, primarily glutamatergic neurons that were able to fire action potentials after ∼8 weeks in culture. Early differentiating neurons expressed a number of transcription factors/chromatin remodeling proteins and synaptic proteins relevant to SZ pathogenesis, including ZNF804A, RELN, CNTNAP2, CTNNA2, SMARCA2, and NRXN1. Although a small number of lines were developed in this preliminary study, the SZ line containing 22q11.2del showed a significant delay in the reduction of endogenous OCT4 and NANOG expression that normally occurs during differentiation. Constitutive expression of OCT4 has been observed in Dgcr8-deficient mouse embryonic stem cells (mESCs); DGCR8 maps to the 22q11.2-deleted region. These findings demonstrate that the method of inducing neural differentiation employed is useful for disease modeling in SZ and that the transition of iPSCs with 22q11.2 deletions towards a differentiated state may be marked by subtle changes in expression of pluripotency-associated genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017 · cited 2×
“…which have been implicated in SZ, was also assessed by RT-PCR, including the forebrain transcription factor FOXG1 , WNT3A , POU3F2 , MYT1L , RELN , and ZNF804A (Hebert & Fishell, 2008; Hur & Zhou, 2010; O’Donovan et al., 2008; Riley et al., 2010; Vierbuchen et al., 2010; Vrijenhoek et al., 2008).”
BackgroundMethodStructural Variation of Chromosomes in Autism Spectrum Disorder
Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.009 · Cited by 1,815 · cited 4×
“Signifi cant increases were also seen in genes coding for adhesion and adhesion-associated molecules, and synaptic proteins that implicate SZ, bipolar disorder (BD), and ASDs, including CNTNAP2 , RELN , NRXN1 , NLGN1 , and CTNNA2 (shown in Figure 5A), and ANK3 , ST8SIA2 , and PCDH9 (Supplemental Table 3) (Alarcon et a…”
BackgroundInfluentialRare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800 · cited 3×
“…are widely viewed as neurodevelopmental in origin (Fatemi & Folsom, 2009; Geschwind & Levitt, 2007; Gratacos et al., 2008; Guilmatre et al., 2009; Walsh et al., 2008; Weinberger, 1997), and consequently, analyzing brain tissue decades removed from primary etiological events may not address…”
BackgroundAutism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421 · cited 4×
“…family; GWAS and copy variation analysis support the idea that the gene is involved in the development of both SZ and ASD (Alarcon et al., 2008; Friedman et al., 2008; Glessner et al., 2009; O’Dushlaine et al., 2010; Roohi et al., 2009; Scott-Van Zeeland et al., 2010; K. S. Wang et al., 2010).”
BackgroundInfluentialAutism spectrum disorders: developmental disconnection syndromes
Geschwind, D. H., & Levitt, P. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.01.009 · Cited by 1,411
Makeyev, E. V., Zhang, J., Carrasco, M. A., & Maniatis, T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.015 · Cited by 1,395 · cited 1×
“Note also the decrease in PTBP1 expression, which inhibits neuron-specifi c splicing (Makeyev et al., 2007), and the decrease in expression of REST (RE1-silencing transcription factor), which inhibits neuronal gene expression in ESCs and neural stem cells and has been shown to regulate the…”
BackgroundModelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375 · cited 5×
“were able to show signifi cant morphological and molecular differences in differentiating iPSCs derived from patients with SZ versus controls using a neural induction scheme that contained RA (Brennand et al., 2011).”
BackgroundMethodResultInfluentialMarchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H., & Muotri, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.10.016 · Cited by 1,329
Identification of loci associated with schizophrenia by genome-wide association and follow-up
Molecular Genetics of Schizophrenia Collaboration, O'Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., Nikolov, I., Hamshere, M., Carroll, L., et al. (2008) · Nature Genetics · doi:10.1038/ng.201 · Cited by 1,070
A microRNA array reveals extensive regulation of microRNAs during brain development
KRICHEVSKY, A. M., KING, K. S., DONAHUE, C. P., KHRAPKO, K., & KOSIK, K. S. (2003) · RNA · doi:10.1261/rna.5980303 · Cited by 1,040 · cited 1×
“…, JARID2 , MYT1L (shown in Figure 5A), and NPAS3 (Supplemental Table 3) (Deo et al., 2006; Huang et al., 2010; Kamnasaran et al., 2003; Koga et al., 2009; Krichevsky et al., 2003, 2006; Loe-Mie et al., 2010; Pedrosa et al., 2007; Pickard et al., 2009; Riley et al., 2010; Vrijenhoek et al., 2008).”
Cited by
Neural Stem Cells: Generating and Regenerating the Brain
Gage, F. H., & Temple, S. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.037 · Cited by 574
Induced pluripotent stem cells: the new patient?
Bellin, M., Marchetto, M. C., Gage, F. H., & Mummery, C. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3448 · Cited by 431
Complement System in Neural Synapse Elimination in Development and Disease
Presumey, J., Bialas, A. R., & Carroll, M. C. (2017) · Advances in Immunology · doi:10.1016/bs.ai.2017.06.004 · Cited by 276
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Dollé, J.-P., Jaye, A., Anderson, S. A., Ahmadzadeh, H., Shenoy, V. B., & Smith, D. H. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.11.001 · Cited by 128
The emerging role of microRNAs in schizophrenia and autism spectrum disorders
Mellios, N., & Sur, M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00039 · Cited by 120
“Lastly, the emerging technologies of induced neurons (Ambasudhan et al., 2011), or induced pluripotent stem cell-derived (Pedrosa et al., 2011) neurons, from patient fibroblasts might be an alternative for uncovering novel miRNA biomarkers, as well as for discovering new treatment options.”
Background
Metadata
- Authors
- Pedrosa, E., Sandler, V., Shah, A., Carroll, R., Chang, C., Rockowitz, S., Guo, X., Zheng, D., & Lachman, H. M.
- Venue
- Journal of Neurogenetics
- Publisher
- Informa UK Limited
- Published
- 2011-07-29
- Volume
- 25
- Issue
- 3
- Pages
- 88-103
- ISSN
- 0167-7063 (ISSN-L)
- 1563-5260
- OpenAlex
- W1966171594
- Cited by
- 129
- References
- 42
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.